Exelixis

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Exelixis and other ETFs, options, and stocks.

About EXEL

Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic.

CEO

Michael M. Morrissey

CEOMichael M. Morrissey

Employees

1,310

Employees1,310

Headquarters

Alameda, California

HeadquartersAlameda, California

Founded

1994

Founded1994

Employees

1,310

Employees1,310

EXEL Key Statistics

Market cap

6.92B

Market cap6.92B

Price-Earnings ratio

36.69

Price-Earnings ratio36.69

Dividend yield

—

Dividend yield—

Average volume

2.06M

Average volume2.06M

High today

$23.80

High today$23.80

Low today

$23.37

Low today$23.37

Open price

$23.68

Open price$23.68

Volume

580.70K

Volume580.70K

52 Week high

$24.34

52 Week high$24.34

52 Week low

$18.08

52 Week low$18.08

EXEL News

Investor's Business Daily 2d

Exelixis Getting Closer To Key Technical Benchmark - Investor's Business Daily

Exelixis (EXEL) had its Relative Strength (RS) Rating upgraded from 69 to 75 Tuesday — a welcome improvement, but still short of the 80 or better score you look...

Simply Wall St 3d

Exelixis, Inc.'s Earnings Haven't Escaped The Attention Of Investors - Simply Wall St

Exelixis, Inc.'s ( ) price-to-earnings (or "P/E") ratio of 32x might make it look like a strong sell right now compared to the market in the United States, wher...

Analyst ratings

68%

of 22 ratings

Buy

68.2%

Hold

27.3%

Sell

4.5%